Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

80.91
Delayed Data
As of Jan 19
 -1.61 / -1.95%
Today’s Change
71.46
Today|||52-Week Range
103.73
+9.83%
Year-to-Date
3 Beaten-Down Biotech Stocks You Can Buy Right Now
Jan 19 / MotleyFool.com - Paid Partner Content
Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
Jan 12 / Zacks.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
Jan 19 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Concert Offers Update on Cystic Fibrosis Drug, Stock Down
Jan 18 / Zacks.com - Paid Partner Content
5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
Jan 09 / MotleyFool.com - Paid Partner Content
Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge
Jan 18 / Zacks.com - Paid Partner Content
Vertex Pharma Issues Disappointing 2017 Orkambi Outlook
Jan 09 / Zacks.com - Paid Partner Content
Why Vertex Pharmaceuticals Stock Sank 42% in 2016
Jan 17 / MotleyFool.com - Paid Partner Content